Scarica l'app Stockscreener
2.535
0.42%
0.015
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CLOV Giù?
Forum
Previsione
Precedente Chiudi:
$2.52
Aprire:
$2.52
Volume 24 ore:
1.92M
Relative Volume:
0.22
Capitalizzazione di mercato:
$1.07B
Reddito:
$1.70B
Utile/perdita netta:
$-123.70M
Rapporto P/E:
-9.5193
EPS:
-0.2663
Flusso di cassa netto:
$-178.21M
1 W Prestazione:
-3.41%
1M Prestazione:
-13.92%
6M Prestazione:
-43.64%
1 anno Prestazione:
-18.36%
Intervallo 1D:
$2.47
$2.54
Intervallo di 1 settimana:
$2.47
$2.725
Portata 52W:
$2.12
$4.87
Clover Health Investments Corp Stock (CLOV) Company Profile
Nome
Clover Health Investments Corp
Settore
Industria
Telefono
(201) 432-2133
Indirizzo
30 MONTGOMERY STREET, JERSEY CITY
Confronta CLOV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
2.535 | 1.34B | 1.70B | -123.70M | -178.21M | -0.2663 |
|
UNH
Unitedhealth Group Inc
|
297.63 | 279.39B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
71.04 | 89.00B | 386.46B | 4.49B | 4.78B | 3.58 |
|
CI
Cigna Group
|
304.40 | 79.63B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
312.39 | 69.65B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
286.40 | 34.54B | 123.11B | 1.58B | 2.44B | 13.03 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Iniziato | Craig Hallum | Buy |
| 2024-10-07 | Iniziato | UBS | Neutral |
| 2022-02-02 | Iniziato | Canaccord Genuity | Buy |
| 2022-02-02 | Aggiornamento | Cowen | Underperform → Market Perform |
| 2022-01-19 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-01-10 | Ripresa | Citigroup | Neutral |
| 2022-01-07 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | Iniziato | Cowen | Underperform |
| 2021-09-02 | Ripresa | Citigroup | Neutral |
| 2021-07-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-06-10 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-05-17 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-03-09 | Iniziato | Credit Suisse | Neutral |
| 2021-02-02 | Iniziato | Citigroup | Buy |
| 2021-02-01 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Clover Health Investments Corp Borsa (CLOV) Ultime notizie
Clover Health Investments, Corp. Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Clover Health Investments, Corp. Rings the Closing Bell - Nasdaq
Will Clover Health Investments Corp. benefit from macro trendsBull Run & Verified Trade Idea Suggestions - Newser
Why Clover Health Investments Corp. stock attracts strong analyst attention2025 Key Highlights & Daily Stock Trend Watchlist - theviewers.co.kr
'SPAC King' Chamath Palihapitiya Returns With $250 Million 'American Exceptionalism' Deal Targeting AI, Energy, DefenseClover Health Investments (NASDAQ:CLOV), Opendoor Technologies (NASDAQ:OPEN) - Benzinga
Support Zone Holds Steady for Clover Health Investments Corp. After DipStop Loss & Comprehensive Market Scan Insights - sundaytimes.kr
Drawdown in Clover Health Investments Corp. May Be Nearing End2025 Trading Recap & Free Weekly Chart Analysis and Trade Guides - newsimpact.co.kr
Ichimoku Cloud Indicates Uncertainty Around Clover Health Investments Corp.2025 Institutional Moves & Safe Entry Trade Reports - sundaytimes.kr
Canaccord Lowers Clover Health (CLOV) PT to $4.10 Despite Strong Q2 Growth - Yahoo Finance
Clover Health (CLOV) Achieves Profitability as Medicare Advantage Membership Surges - Insider Monkey
13 Most Promising Penny Stocks Under $5 - Insider Monkey
Is now the right time to enter Clover Health Investments Corp.July 2025 Analyst Calls & Daily Entry Point Trade Alerts - thegnnews.com
Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth - ADVFN Brasil
Clover drops despite Q2 beat amid concerns over medical cost trends - MSN
Is Clover Health (CLOV) Reassessing Its Path to Profitability After Latest Shift to Net Loss? - simplywall.st
Clover Health Investments Director Loengard Anna U Buys 12000 Shares at $2.6/Share - AInvest
Loengard Anna U buys Clover Health investments (CLOV) shares By Investing.com - Investing.com Canada
Can Clover Health Investments Corp. Overcome Bearish SentimentJuly 2025 Macro Moves & AI Enhanced Market Trend Forecasts - metal.it
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know - ca.finance.yahoo.com
Clover Health rises after former CEO buys shares - MSN
Clover Health Addresses Shareholder Concerns with FAQ Release - AInvest
Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction - The Globe and Mail
Clover Health at Canaccord Conference: Strategic Tech-Driven Growth - Investing.com
Clover Health Investments : August 2025 Investor Presentation - MarketScreener
Clover Health Engages Shareholders with FAQ Release - TipRanks
Clover Health Set To Join Russell 3000® Index - Barchart.com
Insider Buying at Clover Health: A Signal of Value or Short-Term Confidence? - AInvest
Clover Health rises after former CEO buys shares (CLOV) - Seeking Alpha
Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential (NASDAQ:CLOV) - Seeking Alpha
Clover Health Stock (CLOV): Insider Confidence Sparks Rally - Value The Markets
Co-Founder & Executive Chairman of Clover Health Investments Vivek Garipalli Buys 32% More Shares - simplywall.st
Clover Health Investments Maintains Hold Rating from Leerink Partners, Price Target at $2.50 - AInvest
Clover Health 2025 Q2 Earnings Net Loss Widens by 242.8% - AInvest
CLOVER HEALTH INVESTMENTS, CORP. /DE SEC 10-Q Report - TradingView
Clover Health Earnings Call: Growth and Profitability Insights - The Globe and Mail
Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2025 Earnings Call Transcript - Insider Monkey
Clover Health Investments Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Clover Health shares rise 1.33% premarket after 2Q25 earnings call and UBS price target adjustment. - AInvest
Clover Health CEO Reynoso sells $19,718 in shares By Investing.com - Investing.com Canada
Clover Health CEO Reynoso sells $19,718 in shares - Investing.com India
Clover Health Reports Strong Q2 2025 Growth - The Globe and Mail
Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates - MSN
Clover Health stock drops on Q2 report release - Nashville Post
Clover stock drops despite Q2 beat (CLOV:NASDAQ) - Seeking Alpha
Clover Health Posts Rising Revenue And Beats Profit Targets - Finimize
Clover Health Investments Corp Azioni (CLOV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Clover Health Investments Corp Azioni (CLOV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Garipalli Vivek | Director |
Aug 07 '25 |
Buy |
2.24 |
415,000 |
929,600 |
1,824,267 |
| Garipalli Vivek | Director |
Aug 08 '25 |
Buy |
2.17 |
31,980 |
69,397 |
1,856,247 |
| Reynoso Jamie L. | CEO, Medicare Advantage |
Aug 04 '25 |
Sale |
2.89 |
6,823 |
19,718 |
3,261,485 |
0.29%
0.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):